Measuring the Impact of Patient Engagement: A Novartis Perspective

In this episode of Pep Talks, Emma interviews Michaela Dinboeck, the Head of Patient Engagement at Novartis. Michaela discusses her role in integrating patient perspectives into the development and R&D lifecycle at Novartis, emphasizing the importance of patient-focused drug development. She shares insights on the challenges and successes of building a robust patient engagement function within a large organisation, highlighting the significance of measuring impact and capability building. Michaela also reflects on her personal journey and the inspiration she draws from historical movements like the suffragettes. The conversation underscores the ongoing efforts and future challenges in professionalising patient engagement and ensuring it becomes a mainstream practice in the pharmaceutical industry.